{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ARAV",
        "Security_Name": "Aravive, Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "Q",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ARAV",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 2,
                "buy": 4,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 2,
                "buy": 4,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 1.61,
        "open": 1.6,
        "dayLow": 1.55,
        "dayHigh": 1.7699,
        "regularMarketPreviousClose": 1.61,
        "regularMarketOpen": 1.6,
        "regularMarketDayLow": 1.55,
        "regularMarketDayHigh": 1.7699,
        "payoutRatio": 0,
        "beta": 2.20081,
        "forwardPE": -0.8106796,
        "volume": 275957,
        "regularMarketVolume": 275957,
        "averageVolume": 648417,
        "averageVolume10days": 108340,
        "averageDailyVolume10Day": 108340,
        "bid": 1.62,
        "ask": 1.7,
        "bidSize": 800,
        "askSize": 1800,
        "marketCap": 35025744,
        "fiftyTwoWeekLow": 0.58,
        "fiftyTwoWeekHigh": 2.81,
        "priceToSalesTrailing12Months": 5.7381625,
        "fiftyDayAverage": 1.449,
        "twoHundredDayAverage": 1.18508,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2021",
                    "actual": -0.53,
                    "estimate": -0.46
                },
                {
                    "date": "4Q2021",
                    "actual": -0.62,
                    "estimate": -0.6
                },
                {
                    "date": "1Q2022",
                    "actual": -0.62,
                    "estimate": -0.53
                },
                {
                    "date": "2Q2022",
                    "actual": -0.61,
                    "estimate": -0.59
                }
            ],
            "currentQuarterEstimate": -0.64,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1680048000,
                1680480000
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 1371000,
                    "earnings": -76333000
                },
                {
                    "date": 2019,
                    "revenue": 4753000,
                    "earnings": -18218000
                },
                {
                    "date": 2020,
                    "revenue": 5685000,
                    "earnings": -30543000
                },
                {
                    "date": 2021,
                    "revenue": 7442000,
                    "earnings": -39151000
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 2412000,
                    "earnings": -11086000
                },
                {
                    "date": "4Q2021",
                    "revenue": 985000,
                    "earnings": -12956000
                },
                {
                    "date": "1Q2022",
                    "revenue": 1092000,
                    "earnings": -13057000
                },
                {
                    "date": "2Q2022",
                    "revenue": 1615000,
                    "earnings": -18477000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1680048000,
                1680480000
            ],
            "earningsAverage": -0.64,
            "earningsLow": -0.69,
            "earningsHigh": -0.54,
            "revenueAverage": 970000,
            "revenueHigh": 2100000
        },
        "dividendDate": "2018-10-16T00:00:00.000Z"
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-10-25T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-06-03T00:00:00.000Z",
                "firm": "Roth Capital",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-03-08T00:00:00.000Z",
                "firm": "BTIG",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-09-18T00:00:00.000Z",
                "firm": "William Blair",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-07-23T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-03-27T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-12-20T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-12-10T00:00:00.000Z",
                "firm": "Cantor Fitzgerald",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-11-20T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "reit"
            },
            {
                "epochGradeDate": "2019-11-19T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-10-10T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-05-13T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-04-09T00:00:00.000Z",
                "firm": "Wedbush",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "postMarketChangePercent": -0.0299401,
        "postMarketChange": -0.05,
        "postMarketTime": "2023-01-06T22:34:04.000Z",
        "postMarketPrice": 1.62,
        "postMarketSource": "FREE_REALTIME",
        "regularMarketChangePercent": 0.037267044,
        "regularMarketChange": 0.059999943,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 4,
        "regularMarketPrice": 1.67,
        "regularMarketDayHigh": 1.7699,
        "regularMarketDayLow": 1.55,
        "regularMarketVolume": 275957,
        "averageDailyVolume10Day": 108340,
        "averageDailyVolume3Month": 648417,
        "regularMarketPreviousClose": 1.61,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 1.6,
        "exchange": "NMS",
        "exchangeName": "NasdaqGS",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ARAV",
        "underlyingSymbol": null,
        "shortName": "Aravive, Inc.",
        "longName": "Aravive, Inc.",
        "currency": "USD",
        "quoteSourceName": "Nasdaq Real Time Price",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 35025744
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": -9577818,
        "forwardPE": -1.0308641,
        "profitMargins": 0,
        "floatShares": 610365,
        "sharesOutstanding": 20973500,
        "sharesShort": 196965,
        "sharesShortPriorMonth": 307213,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.0064999997,
        "heldPercentInsiders": 0.41513002,
        "heldPercentInstitutions": 0.18327999,
        "shortRatio": 1.57,
        "shortPercentOfFloat": 0.0101,
        "beta": 2.20081,
        "category": null,
        "bookValue": 2.916,
        "priceToBook": 0.57270235,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -55576000,
        "trailingEps": -1.934,
        "forwardEps": -2.06,
        "pegRatio": 0,
        "lastSplitFactor": "1:6",
        "lastSplitDate": "2018-10-16T00:00:00.000Z",
        "enterpriseToRevenue": -1.569,
        "enterpriseToEbitda": 0.163
    },
    "summaryProfile": {
        "address1": "River Oaks Tower",
        "address2": "Suite 1200 3730 Kirby Drive",
        "city": "Houston",
        "state": "TX",
        "zip": "77098",
        "country": "United States",
        "phone": "936 355 1910",
        "website": "https://aravive.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics (Hong Kong) Limited to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.",
        "fullTimeEmployees": 23,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 1.67,
        "targetHighPrice": 18,
        "targetLowPrice": 6,
        "targetMeanPrice": 10.6,
        "targetMedianPrice": 10,
        "recommendationMean": 1.7,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 5,
        "totalCash": 46833000,
        "totalCashPerShare": 1.535,
        "ebitda": -58731000,
        "totalDebt": 5211000,
        "quickRatio": 2.181,
        "currentRatio": 2.389,
        "totalRevenue": 6104000,
        "debtToEquity": 17.332,
        "revenuePerShare": 0.261,
        "returnOnAssets": -0.5284,
        "returnOnEquity": -1.18091,
        "grossProfits": -30099000,
        "freeCashflow": -23997376,
        "operatingCashflow": -48917000,
        "revenueGrowth": -0.574,
        "grossMargins": 0,
        "ebitdaMargins": 0,
        "operatingMargins": -9.7731,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}